Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 433-440

  Drago, L ^a,b   Vassena, C ^a   Dozio, E ^c   Corsi, M M ^c   De Vecchi, E ^a   Mattina, R ^c   Romano C ^a  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Markers of inflammation; Orthopaedic infections; Procalcitonin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; PROCALCITONIN; ANTIINFECTIVE AGENT; AUTACOID; CALCITONIN; IL6 PROTEIN, HUMAN; PROTEIN PRECURSOR;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; JOINT PROSTHESIS; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; PERIOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROTEIN BLOOD LEVEL; BLOOD; HIP ARTHROPLASTY; HIP PROSTHESIS; IMMUNOLOGY; INFECTION; INSTRUMENTATION; ITALY; KNEE ARTHROPLASTY; KNEE PROSTHESIS; METABOLISM; MICROBIOLOGY; PREDICTIVE VALUE; REOPERATION; TIME; TREATMENT OUTCOME; INFECTIOUS ARTHRITIS; PATHOGEN CLEARANCE; PROSTHESIS FAILURE; PROSTHESIS LOOSENING; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ANTI-BACTERIAL AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HIP PROSTHESIS; HUMANS; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-6; ITALY; KNEE PROSTHESIS; MALE; PREDICTIVE VALUE OF TESTS; PROSTHESIS-RELATED INFECTIONS; PROTEIN PRECURSORS; REOPERATION; TIME FACTORS; TREATMENT OUTCOME;

EID: 80051778848     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400216     Document Type: Article

References (39)

1. Black S, Kushner I, Samols D. C-reactive Protein. J Biol Chem 2004; 79:48487-90. (Pubitemid 39625721)
2. Liu F, Whang Q, Zeng FY, Zhang P, Nan Fang Yi, Ke Da Xue Xue Bao. Clinical diagnostic value of PCT detection in local infections 2010; 30:614-19.
3. Trampuz A, Zimmerli W. Prosthetic joint infection: update in diagnosis and treatment. Swiss Med Wkly 2005; 135:243-51. (Pubitemid 40769561)
4. Didebulidze K, Manjavidze N, Ubiria I, Gogberashvili K. Procalcitonin, marker of severe infection and sepsis. Georgian Med News 2007; 153:22-7.
5. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003; 111:1805-12. (Pubitemid 38057722)
6. Naugler WE, Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008; 14:109-19.
7. Witkowska AM, Borawska MH. Soluble intercellular adhesion molecule-1 (sICAM-1): an overview. Eur Cytokine Netw 2004; 15:91-8. (Pubitemid 38980081)
8. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Gotze C. Interleukin-6, procalcitonin and tumor necrosis factor-α: markers of peri-prothesic infection following total join replacement. J Bone Surg Br 2007; 89:94-9.
9. Robledo O, Papaioannou A, Ochietti B, et al. ICAM-1 isoforms: specific activity and sensitivity to cleavage by leukocyte elastase and cathepsin G. Eur J Immunol 2003; 33:1351-60. (Pubitemid 36609153)
10. Cichy J, Rose-John S, Pryjma J, Travis J. Effect of soluble interleukin-6 receptor in IL-6 synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1996; 227:318-21. (Pubitemid 26362804)
11. Kestler DP, Agarwal S, Cobb J, Goldstein KM, Hall RE. Detection and analysis of an alternatively spliced isoform of interleukin-6 mRNA in peripheral blood mononuclear cells. Blood 1995; 86:4559-67.
12. May LT, Helfgott DC, Sehgal PB. Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved. Proc Natl Acad Sci USA 1986; 83:8957-61. (Pubitemid 17223520)
13. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147:3788-93.
14. Hatzistilianou M. Diagnostic and prognostic role of procalcitonin in infections. Scientific World Journal 2010; 10:1941-6.
15. Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA. Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 1988; 52:925-33.
16. Fiore E, Fusco C, Romero P, Stamenkovic I. Matrix metalloproteases 9 (MMP-9/gelatinase B) proteolytically clave ICAM-1 and partecipates in tumor cell resistance to natural killer cell-mediated cytotoxiticy. Oncogene 2002; 21:5213-23. (Pubitemid 34948133)
17. Reilly PL, Woska JR Jr, Jeanfavre DD, McNally E, Rothlein R, Bormann BJ. The native structure of intercellular adhesion molecule-1 (ICAM-1) is a dimer. Correlation with binding to LFA-1. J Immunol 1995; 155:529-32.
18. Jones KJ, Perris AD, Vernallis AB, Worthington T, Lambert PA, Elliott TS. Induction of inflammatory cytokines and nitric oxide in J774.2 cells and murine macrophages by lipotechoic acid and related cell wall antigens from Staphilococcus epidermidis. J Med Microbiol 2005; 54:315-21. (Pubitemid 40489535)
19. Walsh MT, Divane A, Whitehead AS. Fine mapping of the human pentraxin gene region on chromosome 1q23. Immunogenetics 1996; 44:62-9. (Pubitemid 26131485)
20. Diamond MS, Staunton DE, De-Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, Springer TA. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990; 111:3129-39. (Pubitemid 120034048)
21. Hogg N, Bates PA, Harvey J. Structure and function of intercellular adhesion molecule-1. Chem Immunol 1991; 50:98-115.
22. Jun CD, Shimaoka M, Carman CV, Takagi J, Springer TA. Dimerization and the effectiveness of ICAM-1 in mediating LFA-1-dependent adhesion. Proc Natl Acad Sci USA 2001; 98:6830-5. (Pubitemid 32538302)
23. Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin ML. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med 1995; 182:1231-41.
24. Pluskota E, D'Souza SE. Fibrinogen interactions with ICAM-1 (CD54) regulate endothelial cell survival. Eur J Biochem 2000; 267:4693-704. (Pubitemid 30619459)
25. Rose-John S, Scheller J, Elson G, Jones SA. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. J Leukoc Biol 2006; 80:227-36. (Pubitemid 44835496)
26. Langston W, Chidlow JH Jr, Booth BA, Barlow SC, Lefer J, Patel RP, Kevil CG. Regulation of endothelial glutathione by ICAM-1 governs VEGF-A-mediated eNOS activity and angiogenesis. Free Radic Biol Med 2007; 42:720-9. (Pubitemid 46205151)
27. Lavigne P, Benderdour M, Shi Q, Lajeunesse D, Fernandes JC. Involvement of ICAM-1 in bone metabolism: a potential target in the treatment of bone diseases? Expert Opin Biol Ther 2005; 5:313-20. (Pubitemid 40516742)
28. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, D'Souza SE. Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 2006; 281:3157-64. (Pubitemid 43845925)
29. Jander S, Heidenreich F, Stoll G. Serum and CSF levels of soluble intercellular adhesion molecule-1 (ICAM-1) in inflammatory neurologic diseases. Neurology 1993; 43:1809-13. (Pubitemid 23307960)
30. Melis M, Pace E, Siena L, et al. Biologically active intercellular adhesion molecule-1 is shed as dimers by a regulated mechanism in the inflamed pleural space. Am J Respir Crit Care Med 2003; 167:1131-8. (Pubitemid 36459661)
31. Rosenstein Y, Park JK, Hahn WC, Rosen FS, Bierer BE, Burakoff SJ. CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 1991; 354:233-5. (Pubitemid 21896822)
32. Sithu SD, English WR, Olson P, Krubasik D, Baker AH, Murphy G, D'Souza SE. Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration. J Biol Chem 2007; 282:25010-9. (Pubitemid 47347548)
33. Benson V, McMahon AC, Lowe HC. ICAM-1 in acute myocardial infarction: a potential therapeutic target. Curr Mol Med 2007; 7:219-27. (Pubitemid 46488192)
34. Teppo AM, Von Willebrand E, Honkanen E, Ahonen J, Grönhagen-Riska C. Soluble intercellular adhesion molecule-1 (sICAM-1) after kidney transplantation: the origin and role of urinary sICAM-1? Transplantation 2001; 71:1113-9. (Pubitemid 32448828)
35. Trampuz A, Steinrücken J, Clauss M, Bizzini A, Furustrand U, Uçkay I, Peter R, Bille J, Borens O. New methods for the diagnosis of implant-associated infections. Rev Med Suisse 2010; 6:731-4.
36. Koudela K Jr, Geigerovà L, Hes O, Koudela K Sr. Comprehensive diagnosis of infection in revision total replacements of large joints. Acta Chir Orthop Traumatol Cech 2010; 77:425-31.
37. Assicot M, Gendrel B, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-18. (Pubitemid 23066085)
38. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010; 2010:535918 Epub.
39. De Cesare PE, Chang E, Preston CF, Liu J. Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg AM 2005; 87:1921-7. (Pubitemid 41279121)